s.vogel

TL2 · Cali

Contributes reviews on supplier material. Based in Cali.

Joined 8 November 2024 · last posted 2d

82 posts, newest first. Showing up to 150.

[2026 update] Regional warehouse stock versus direct despatch Replied, post #148 · Sourcing › Logistics · 26 Jul 2026 · 0 likes If you are new and reading this thread for the answer to Regional warehouse stock versus direct: the answer is conditional, the conditions are in the third reply, and…
Here for the analytics and not much else Replied, post #98 · Lounge › Introductions · 26 Jul 2026 · 5 likes Welcome. The short version of the culture: be specific, date everything, and say when you are guessing. That is genuinely the whole of it.
What a certificate commits its issuer to Replied, post #108 · Analytics › COA interpretation · 26 Jul 2026 · 6 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Alcohol: what is documented and what is folklore Replied, post #130 · Practice › Interactions · 24 Jul 2026 · 32 likes That is clearer than the version I had in my head. Thank you.
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #42 · Practice › Dosing & titration · 23 Jul 2026 · 7 likes Going back down a step is not a failure and the trials allowed it. Several protocols permitted a return to the previous dose for tolerability and then a second attempt…
Follow-up: How compounding permissions changed when supply normalised Replied, post #57 · Sourcing › Regulatory · 22 Jul 2026 · 0 likes Adding the measurement that post #54 says would settle it. If you can confirm or contradict a position for your own region, please date the answer. An undated regional…
Follow-up: Signs of dehydration worth acting on Replied, post #34 · Safety › Adverse events · 22 Jul 2026 · 0 likes Two questions I would want answered before drawing anything from the Signs of dehydration worth acting data above: how were the cases selected, and what happened to the…
Journal club: orforglipron phase 2 and the non-peptide question Replied, post #126 · Evidence › Journal club · 20 Jul 2026 · 21 likes Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one.
Insurance and replacement policies, compared Replied, post #98 · Sourcing › Logistics · 18 Jul 2026 · 16 likes This follows post #96 rather than contradicting it. Filing a mild objection to the consensus on insurance and replacement policies. Mild because I might be wrong; an…
[2026 update] Detection wavelength and why 214 nm and 280 nm disagree Replied, post #43 · Analytics › HPLC & UHPLC · 17 Jul 2026 · 31 likes I read post #42 twice before replying, because I had assumed the opposite. Gradient slope is the single biggest driver of apparent purity differences. A shallower…
Revisiting: Taste changes and food aversion, reported and discussed Replied, post #19 · Practice › Side effects · 14 Jul 2026 · 32 likes Constipation is reported at least as often as nausea and is discussed a fraction as much. Fluid, fibre and movement are the boring answers and they are the ones that…
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #72 · Analytics › Impurities & related substances · 13 Jul 2026 · 4 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
Journal club: what we got wrong in an earlier session Replied, post #50 · Evidence › Journal club · 3 Jul 2026 · 27 likes Thank you — that answers what I came here to find out.
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #14 · Evidence › Journal club · 2 Jul 2026 · 4 likes Having read the whole SUSTAIN 6 thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one…
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #88 · Data & Tools › Datasets · 29 Jun 2026 · 0 likes Noted, and thank you for writing it out rather than summarising it.
The anatomy of a question that gets answered within an hour Replied, post #92 · Start Here › How to Ask · 27 Jun 2026 · 0 likes A photograph of a vial is rarely useful and a photograph of a document usually is. Redact the identifiers before you post either. On reflection I would soften that…
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #8 · Compounds › Retatrutide · 20 Jun 2026 · 2 likes No phase 3 results exist for retatrutide. Anything attributed to a completed phase 3 trial of this compound is either a misreading or an invention, and the honest…
Electrolyte supplements: which ones do anything Replied, post #33 · Nutrition & Training › Hydration & electrolytes · 17 Jun 2026 · 3 likes Post #29 put the caveat in the right place and I want to underline it. I would put moderate confidence on the mainstream reading of electrolyte supplements and no more.…
Pooling trials with different estimands Replied, post #28 · Evidence › Meta-analyses · 16 Jun 2026 · 0 likes Coming back to post #26, because the follow-up matters more than the original answer. What I would want before treating pooling trials with different estimands as…
Coming back to: Why our vendor pages link the storefront and mark it sponsored Replied, post #2 · Sourcing › Vendor reports · 11 Jun 2026 · 16 likes Picking up the opening post: that is the part I would want checked first. What "verified" means on our pages: specific lots were independently measured on stated dates…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #22 · Practice › Reconstitution · 2 Jun 2026 · 8 likes How much of the diluent volume the powder itself displaces: for a small peptide vial, the powder volume is negligible. For a larger vial or a kit with multiple…
Injection volume, overload, and peak distortion Replied, post #28 · Analytics › HPLC & UHPLC · 31 May 2026 · 1 like Typical suitability criteria are a replicate area relative standard deviation below about two per cent, a tailing factor inside a defined window, a resolution minimum…
Reference intervals: how they are constructed and why one in twenty flags Replied, post #94 · Clinical › Bloodwork · 9 May 2026 · 2 likes Where the reference intervals reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #15 · Evidence › Journal club · 7 May 2026 · 25 likes Answering the question post #11 raises rather than the one it answers. Second-hand on STEP 1, so weight it accordingly — someone whose method I trust told me this and I…
The "under review" status pill and when a moderator applies it Replied, post #114 · Evidence › Preprints · 4 May 2026 · 0 likes Fine by me. I had wanted a stronger conclusion and there is not one available.
[2026 update] Regional warehouse stock versus direct despatch Replied, post #49 · Sourcing › Logistics · 22 Apr 2026 · 17 likes I had written a reply contradicting post #47 and deleted it. Here is what survived. Regional warehouse stock versus direct came up in a thread eighteen months ago and…
Converting between mg/mL and units per dose, both directions — the long version Replied, post #55 · Practice › Reconstitution · 21 Apr 2026 · 0 likes Confirming post #54 from a second method, which matters more than confirming it from a second person. Preservative effectiveness is tested against a defined microbial…
[2026 update] Composite endpoints and the component doing the work Replied, post #78 · Evidence › Trials · 20 Apr 2026 · 0 likes Post #77 is right about the mechanism and I think understates the practical bit. Composite endpoints should be read component by component. A composite driven entirely…
Sample handling between despatch and injection Replied, post #48 · Analytics › Method validation · 18 Apr 2026 · 22 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
Revisiting: Drawing up with one needle and injecting with another Replied, post #9 · Practice › Administration · 1 Apr 2026 · 10 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
AOD-9604 and the fragment hypothesis, revisited — does this still hold? Replied, post #6 · Compounds › Other compounds · 29 Mar 2026 · 8 likes What I want from this AOD-9604 thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it.
Journal club: SURMOUNT-4 and continuation versus withdrawal Replied, post #14 · Evidence › Journal club · 24 Mar 2026 · 5 likes Before the thread moves on from SURMOUNT-4 and continuation versus withdrawal — what is the sample size behind the claim? I am not being difficult; I have seen the same…
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #80 · Practice › Storage & stability · 12 Mar 2026 · 19 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. The general…
Measurement error in a self-reported exposure Replied, post #4 · Evidence › Study critique · 21 Feb 2026 · 1 like Post #2 describes the usual case. This is about the unusual one. What I would tell a new member reading about measurement error for the first time: the confident posts…
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #100 · Compounds › Semaglutide · 22 Jan 2026 · 0 likes This is the first time the answer has come with its own limits attached. Appreciated.
Warfarin and altered intake: the monitoring argument — the long version Replied, post #94 · Practice › Interactions · 21 Jan 2026 · 1 like Picking up post #92: that is the part I would want checked first. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not…
Common supplements people ask about, assessed one at a time — a second dataset Replied, post #33 · Practice › Interactions · 10 Jan 2026 · 30 likes Reading back through the Common supplements threads from last year, the same three questions come up every time and only one of them has ever been answered properly.…
Pregnancy and pregnancy planning: contraindication and washout Replied, post #7 · Clinical › Special populations · 4 Jan 2026 · 0 likes That is clearer than the version I had in my head. Thank you.
Preprint servers and what screening they do Replied, post #14 · Evidence › Preprints · 3 Jan 2026 · 2 likes Building anything durable on a preprint means committing to rebuild it. That is a reasonable trade for a fast-moving question and it should be an explicit one.
Vomiting: when it is expected and when it is a reason to stop Replied, post #64 · Practice › Side effects · 28 Dec 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
Tracking a preprint to publication: a worked example Replied, post #63 · Evidence › Preprints · 6 Dec 2025 · 2 likes Where I part company with post #61, and it is a narrow parting. A preprint that has been up for two years without appearing in a journal is telling you something, and…
"Greater than or equal to 99%" as a specification rather than a result Replied, post #80 · Analytics › COA interpretation · 29 Nov 2025 · 16 likes Post #78 and I disagree about the size of the effect, not about the direction. The distinction between release testing and characterisation is one industrial documents…
What a purity-only report leaves out Replied, post #94 · Sourcing › Independent verification · 19 Nov 2025 · 1 like Adding a null result on purity-only. I looked, carefully, and found nothing, and null results deserve posting precisely because they never are.
What a purity-only report leaves out Replied, post #77 · Sourcing › Independent verification · 7 Nov 2025 · 0 likes It does not extend to lots nobody has seen, it is not a recommendation, and it says nothing about anything other than what was measured. The general case is well…
Reconciling a supplier certificate with an independent result Replied, post #20 · Sourcing › Vendor reports · 1 Nov 2025 · 19 likes Lot matching: confirm the lot number on the certificate matches the lot number on the vial. A result from a different lot is not evidence about your vial. Worth reading…
Research-use-only labelling: what it means and what it does not Replied, post #51 · Sourcing › Regulatory · 27 Oct 2025 · 0 likes An honest declaration on research-use-only labelling: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than…
A 40-week log with the measurement method stated Replied, post #66 · Outcomes › Progress reports · 25 Oct 2025 · 29 likes Seasonal patterns: some people report weight loss is slower in winter than summer. Body composition and activity changes might contribute. Noting the season is useful…
Documentation that appears only after payment Replied, post #55 · Sourcing › Red flags · 22 Oct 2025 · 11 likes Exaggerated claims without documentation: every compound has limits. No peptide is "100% pure" because purity is measured to finite precision. A supplier claiming…
History of disordered eating and why it changes the conversation Replied, post #16 · Clinical › Special populations · 6 Oct 2025 · 3 likes Post #12 describes the usual case. This is about the unusual one. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes…
Freeze-thaw and why one cycle is not the same as five Replied, post #6 · Practice › Storage & stability · 29 Sep 2025 · 20 likes Small methodological point on freeze-thaw: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.
Washout: how long is long enough, and for what purpose Replied, post #70 · Pharmacology › Pharmacokinetics · 25 Sep 2025 · 0 likes Confirming post #67 from a second method, which matters more than confirming it from a second person. Where the washout discussion usually stalls is that nobody wants…
Managing an unplanned gap in supply — what changed since Replied, post #65 · Access › Shortages · 18 Sep 2025 · 0 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
Thyroid function tests during substantial weight change Replied, post #51 · Clinical › Bloodwork · 4 Sep 2025 · 5 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason. That matches what I was told, which is not…
Enforcement priorities versus written rules — does this still hold? Replied, post #5 · marked as the solution · Sourcing › Regulatory · 10 Aug 2025 · 21 likes Enforcement practice and legal position are different things and both matter to somebody making a decision. Conflating them is common in both directions. If that is…
A request that was declined, and the reasoning — a second dataset Replied, post #37 · Documentation › Wiki requests · 9 Aug 2025 · 0 likes Narrowing post #35, because the general version has more than one answer. Documents that are mostly a worked example age better than documents that are mostly a…
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #100 · Practice › Reconstitution · 5 Aug 2025 · 24 likes Add the diluent down the side of the vial rather than directly onto the cake. It is slower and it avoids the foaming that makes people think something has gone wrong.…
Why the timeline is on the right and not the left Replied, post #50 · Meta › Site feedback · 5 Aug 2025 · 1 like I had written a reply contradicting post #46 and deleted it. Here is what survived. I would keep timeline and the decision it usually gets used for separate in this…
Travel coolers and how long they really hold Replied, post #30 · Devices › Cold chain · 2 Aug 2025 · 8 likes Coming back to post #26, because the follow-up matters more than the original answer. The thing about travel coolers that took me longest to accept is that a plausible…
Follow-up: The lowest dose that does anything: is that a real question? Replied, post #36 · Practice › Dosing & titration · 30 Jul 2025 · 8 likes I had written a reply contradicting post #32 and deleted it. Here is what survived. Going back down a step is not a failure and the trials allowed it. Several protocols…
Canadian access and provincial variation — one year on Replied, post #41 · Regional › North America · 28 Jul 2025 · 3 likes On Canadian access and provincial variation the community has more anecdote than the confidence in this thread implies, and I include my own contribution in that.
Second pass at: How to ask a question when you cannot say why you are asking it Replied, post #2 · Start Here › How to Ask · 17 Jul 2025 · 0 likes Appreciated. The plain phrasing does more work here than a longer post would.
Follow-up: Tracking intake honestly when appetite is absent Replied, post #67 · Nutrition & Training › Protein & intake · 11 Jun 2025 · 0 likes Answering the question post #66 raises rather than the one it answers. Eating anything at all: on substantial appetite suppression, eating enough total calories to…
DXA precision and the least significant change for lean mass — the long version Replied, post #32 · Outcomes › Body composition · 12 May 2025 · 15 likes Adding the measurement that post #29 says would settle it. If someone has run DXA precision properly I would rather read that than my own reconstruction of it. Posting…
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #78 · Sourcing › Independent verification · 11 May 2025 · 10 likes Genuine question rather than a rhetorical one: has anyone here actually observed Janoshik, as opposed to read about it? The thread is long and I cannot tell.
Follow-up: Requesting a page: what makes a good request Replied, post #16 · Documentation › Wiki requests · 31 Mar 2025 · 15 likes Correction requests: if you spot an error in a maintained page, note it here with the specific correction. The maintainer will review and update if justified. The right…
Scheduled maintenance and what will be unavailable Replied, post #88 · Meta › Announcements · 28 Mar 2025 · 0 likes I have been on both sides of the scheduled maintenance argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
What a 2 ppm match establishes, and what it does not Replied, post #7 · Analytics › Mass spectrometry · 24 Mar 2025 · 30 likes Adding the measurement that post #4 says would settle it. A mass match establishes that the measured mass is consistent with the proposed composition. It does not…
Fibre intake when total intake falls, and the constipation link Replied, post #33 · Nutrition & Training › Protein & intake · 26 Feb 2025 · 19 likes Where somebody reports losing strength, intake and training stimulus are the first two things to look at rather than the compound. Somebody will have a better source…
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #114 · Compounds › Semaglutide · 24 Feb 2025 · 5 likes Where I part company with post #110, and it is a narrow parting. One more thing on Semaglutide half-life that took me far too long to see: the two figures people quote…
Reading a supplier's product description as a marketing document Started this topic · Compounds › Other compounds · 22 Feb 2025 · 0 likes On the subject in the title: Reading a supplier's product description as a marketing document Working notes rather than a conclusion. Documentation question rather than…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly Replied, post #21 · Compounds › Tirzepatide · 14 Feb 2025 · 22 likes The apnoea-hypopnoea index used in SURMOUNT-OSA is an objective measurement rather than a symptom scale, which is why that trial carries more weight than its size…
How compounding permissions changed when supply normalised Replied, post #15 · Sourcing › Regulatory · 3 Feb 2025 · 0 likes Answering the question post #11 raises rather than the one it answers. Nothing in this subcategory is legal advice, and the members who work in regulated environments…
Second pass at: Historical amylin analogues and what happened to them Replied, post #5 · Compounds › Cagrilintide & amylin analogues · 6 Jan 2025 · 2 likes I had read the opposite somewhere and cannot now find where, which tells me something.
What changed in 2026, by region Replied, post #50 · Access › International · 31 Dec 2024 · 5 likes Both are useful and they are different contributions. A first-hand account and a citation answer different halves of the question.
Why "any advice?" is the least effective ending for a post Replied, post #90 · Start Here › How to Ask · 30 Nov 2024 · 0 likes It is fine to say you cannot explain why you are asking. Nobody will press, and the technical part of the question can usually be answered without the context.
Time to steady state after a dose increase Replied, post #92 · Pharmacology › Pharmacokinetics · 5 Nov 2024 · 16 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #21 · Evidence › Journal club · 31 Oct 2024 · 4 likes Answering the question post #17 raises rather than the one it answers. Where the group cannot agree, record the disagreement rather than resolving it by seniority. The…
Coming back to: Renal impairment: what the labelling says about dose Replied, post #10 · Clinical › Special populations · 21 Oct 2024 · 0 likes Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal impairment. Consulting with a clinician familiar…
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #64 · Evidence › Journal club · 5 Oct 2024 · 19 likes For anyone finding this later: the short answer on SURPASS-2 is that it depends on one thing, and the rest of the thread is people identifying which thing.
High-resolution MS on aggregates and what it can see — one year on Replied, post #34 · Analytics › Mass spectrometry · 17 Aug 2024 · 2 likes Post #30 put the caveat in the right place and I want to underline it. What I would want before treating High-resolution as settled: the method, the sample, and whether…
Identical chromatograms across two different lots Replied, post #9 · Sourcing › Red flags · 27 Jul 2024 · 11 likes The useful distinction on identical chromatograms is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them has…
Oral contraceptives and delayed emptying: what the data shows Replied, post #38 · Practice › Interactions · 13 Jul 2024 · 27 likes Marking my uncertainty on oral contraceptives and delayed emptying explicitly. I am confident about the direction, much less confident about the size, and not confident…